Evidence Gaps

Calcineurin inhibitor (CNI) withdrawal vs standard dose CNI

Calcineurin inhibitor withdrawal or tapering for kidney transplant recipients 2017 · Cochrane Headline outcomes only
no estimate extracted
8 studies · 910 participants
Low

Calcineurin inhibitor (CNI) avoidance and late CNI withdrawal vs standard dose CNI

Calcineurin inhibitor withdrawal or tapering for kidney transplant recipients 2017 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 242 participants
Very low

Calcineurin inhibitor withdrawal or tapering for kidney transplant recipients 2017 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 668 participants
Low

Calcineurin inhibitor (CNI) avoidance and late withdrawal with mammalian target of rapamycin inhibitor (mTORi) vs standard dose CNI
GFR: avoidance · kidney transplant recipients
1 finding from 1 review
Calcineurin inhibitor withdrawal or tapering for kidney transplant recipients 2017 · Cochrane Headline outcomes only
no estimate extracted
9 studies · 1748 participants
Low

Calcineurin inhibitor withdrawal or tapering for kidney transplant recipients 2017 · Cochrane Headline outcomes only
no estimate extracted
9 studies · 1748 participants
Low

Calcineurin inhibitor (CNI) avoidance and late withdrawal with mammalian target of rapamycin inhibitor (mTORi) vs standard dose CNI
GFR: late withdrawal · kidney transplant recipients
1 finding from 1 review
Calcineurin inhibitor withdrawal or tapering for kidney transplant recipients 2017 · Cochrane Headline outcomes only
no estimate extracted
14 studies · 2679 participants
Low

Calcineurin inhibitor withdrawal or tapering for kidney transplant recipients 2017 · Cochrane Headline outcomes only
no estimate extracted
14 studies · 2679 participants
Low